Home/Filings/4/0001209191-20-020647
4//SEC Filing

Howarth Alex G. 4

Accession 0001209191-20-020647

CIK 0001662524other

Filed

Mar 22, 8:00 PM ET

Accepted

Mar 23, 4:35 PM ET

Size

7.2 KB

Accession

0001209191-20-020647

Insider Transaction Report

Form 4
Period: 2020-03-19
Howarth Alex G.
Chief Operating Officer
Transactions
  • Award

    Common Stock

    2020-03-19+16,80066,800 total
  • Award

    Stock Option (right to buy)

    2020-03-19+34,20034,200 total
    Exercise: $12.76Exp: 2030-03-18Common Stock (34,200 underlying)
Footnotes (2)
  • [F1]Represents restricted stock unit award granted under the Issuer's 2015 Equity Incentive Plan.
  • [F2]The shares vest as follows: 1/4th of the shares vest one year after March 19, 2020;1/48th of the shares vest monthly thereafter over the next three years.

Issuer

AKCEA THERAPEUTICS, INC.

CIK 0001662524

Entity typeother

Related Parties

1
  • filerCIK 0001795798

Filing Metadata

Form type
4
Filed
Mar 22, 8:00 PM ET
Accepted
Mar 23, 4:35 PM ET
Size
7.2 KB